NCT04745221 Efficacy and Safety of Auto-FMT in Preventing aGVHD
| NCT ID | NCT04745221 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First Affiliated Hospital of Soochow University |
| Condition | Graft Versus Host Disease, Acute |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2021-03-01 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2021-03-01 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluation the efficacy and safety of autologous fecal bacteria transplantation in preventing acute graft versus host disease after haploidentical hematopoietic stem cell transplantation. Bone marrow transplant patients were recruited.
Eligibility Criteria
Inclusion Criteria: * Haplo-HSCT patients; Bacteroidetes \>0.1%; inverse Simpson diversity ≥2 Exclusion Criteria: * Gastrointestinal diseases；Age\>60; or Age\<10；Probiotics or prebiotics were taken before enrollment
Frequently Asked Questions
Who can join the NCT04745221 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Graft Versus Host Disease, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04745221 currently recruiting?
Yes, NCT04745221 is actively recruiting participants. Visit ClinicalTrials.gov or contact The First Affiliated Hospital of Soochow University to inquire about joining.
Where is the NCT04745221 trial being conducted?
This trial is being conducted at Suzhou, China.
Who is sponsoring the NCT04745221 clinical trial?
NCT04745221 is sponsored by The First Affiliated Hospital of Soochow University. The trial plans to enroll 100 participants.